AAIC 2022 and Trial Updates View overview page

Phase II trial of XPro1595 for the treatment of Alzheimer’s disease

EXERT: why was strength/balance training as effective as cardio in preventing cognitive decline?

Successful Aging after Elective Surgery: goals of the SAGES II study

The neurogenesis hypothesis: NA-831 for the treatment of Alzheimer’s disease

Investigating CT1812: an S2R modulator in development for Alzheimer’s disease

Phase II study of S2R modulation in patients with dementia with Lewy bodies

Study of Healthy Aging in African Americans: updates from STAR

TOGETHER study: updates on bepranemab as a potential treatment for AD

Buntanetap shows promise for the treatment of Alzheimer’s disease and Parkinson’s disease

Tackling diet and lifestyle for dementia prevention: new findings

Optimized anti-Aβ vaccination enters clinical trials in Alzheimer’s disease

Clinical trial assessing a multi-nutrient drink in age-related cognitive decline

PASTIS: investigating the impact of tadalafil on cerebral blood flow in small vessel disease

Nutritional interventions to support cognitive performance in aging

Targeting soluble TNF to attenuate neuroinflammation in Alzheimer’s disease

Targeting synaptic function and recovery to tackle cognitive function